The Latest Breaking News from SWAV

ShockWave Medical's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, ShockWave Medical (NASDAQ:SWAV) earned $14.52 million, a 12.2% increase from the preceding quarter. ShockWave Medical also posted a total of $93.63 million in sales, a 11.22% increase since Q4.

Benzinga · Jun 6, 2022

Expert Ratings for ShockWave Medical

Over the past 3 months, 6 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · May 10, 2022

Shockwave Medical Stock Soars On Q1 Earnings Beat, Raised FY22 Guidance

Shockwave Medical Inc (NASDAQ:SWAV) reported first-quarter revenue of $93.63 million, an increase of 193.5% year-over-year, beating the consensus of $86.41 million. The gross margin for Q1 expanded to 86.2% from 75.3% in 1Q21. The operating income for the quarter totaled $15.37 million versus a loss of $(17.48) million a year ago. EPS…

Benzinga · May 9, 2022

ShockWave Medical: Q4 Earnings Insights

ShockWave Medical (NASDAQ:SWAV) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 17, 2022

ShockWave Medical's Earnings: A Preview

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that ShockWave Medical will report an earnings per share (EPS) of $0.08.

Benzinga · Feb 16, 2022